Rigel Pharmaceuticals reported $-27445000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acura Pharmaceuticals ACUR:US -387000 128K
Agenus AGEN:US $ -48.32M 17.19M
Amgen AMGN:US $ 1476M 423M
Anika Therapeutics ANIK:US $ -2.93M 2.86M
Applied Genetic Technologies AGTC:US $ -14.29M 4.85M
Arrowhead Research ARWR:US $ 44.37M 107.24M
AstraZeneca AZN:LN 386M 733M
Astrazeneca AZN:US $ 386M 733M
Biomarin Pharmaceutical BMRN:US $ 120.8M 178.7M
Bristol Myers Squibb BMY:US $ 1278M 1094M
Celldex Therapeutics CLDX:US $ -23.05M 2.9M
Chemocentryx CCXI:US $ -38.61M 1.92M
Daiichi Sankyo 4568:JP Y -27345M 59198M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Halozyme Therapeutics HALO:US $ 60.11M 6.66M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Immunogen IMGN:US $ -24.14M 13.03M
Intrexon XON:US $ -19.25M 5.78M
IONIS PHARMACEUT IONS:US $ -65.17M 289.78M
Karyopharm Therapeutics KPTI:US $ -41399000 80.12M
Ligand Pharmaceuticals LGND:US $ -15.38M 9.97M
Macrogenics MGNX:US $ -66.44M 8.42M
Neurocrine Biosciences NBIX:US $ 13.9M 21.2M
Pfizer PFE:US $ 7863M 4470M
Regeneron Pharmaceuticals REGN:US $ 973.5M 1255.5M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.8M
Sangamo Biosciences SGMO:US $ -43.98M 6.48M
Ultragenyx Pharmaceutical RARE:US $ -152.32M 29.86M
Veracyte VCYT:US $ -14.46M 3.93M